Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ventana holds firm against third extension of Roche bid:

This article was originally published in Clinica

Executive Summary

Ventana Medical Systems has remained steadfast in its opposition of Roche's hostile takeover despite the tender offer being extended until November 1. Ventana issued a statement saying: "This is now the third time that Roche has extended its offer, one which we have previously said is grossly inadequate and one that substantially all of our investors have rejected repeatedly". The previous extension was due to expire on September 20 (see Clinica No 1271, p 3), at which time only 0.2% of Ventana's 34 million outstanding shares had been tendered to the Swiss drugs giant.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT048605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel